The Peninsula Practice is Research Active
NHS research is essential to help shape and improve future NHS healthcare. The Peninsula Practice has been involved in cutting edge national research including a new device to replace endoscopy in some cases. Dr Crockett is the principal investigator for all research at the practice, whereby she checks eligibility for patients to take part in relevant studies. You may therefore receive an invitation which will be directly from The Peninsula Practice to participate in a study - we never share your personal details. You are free to choose whether to take part or not with no obligation. Taking part in clinical research may benefit you, or others like you, in the future.
For further information ask any member of staff who can signpost you to our research nurse. Alternatively click on link below for further information which can be found on or Be Part of Research website.
Be Part Of Research
Current Studies At The Peninsula Practice
PRINCIPLE - This study is an excellent study we’re involved with which is developing cutting edge treatments for Covid.
Ground-breaking COVID-19 antiviral treatment trial opens to recruitment in the East of England
Local GPs and healthcare professionals have today begun enrolling participants across the east of England to a first-of-its-kind clinical trial investigating the effectiveness of new oral antiviral treatments for COVID-19, which can be safely taken at home.
What is the study?
The PANORAMIC (Platform Adaptive trial of NOvel antiviRals for eArly treatMent of covid-19 In the Community) trial will assess a range of new antiviral treatments which could help clinically vulnerable people with COVID-19 in the community recover sooner, prevent the need for hospital admission and ease the burden on the NHS.
Who can join the PANORAMIC study?
Anyone can join the study if they are aged 50 years and over, or between 18 to 49 years with underlying health conditions that make them clinically more vulnerable to serious complications as a result of a COVID-19 infection. All participants also need to have had a positive COVID-19 test and be within five days of the onset of symptoms.
Taking part is easy
People with a positive PCR test for COVID-19 will be contacted by the trial team or a local healthcare professional, such as a GP or a research nurse, to consider enrolling in the study. Alternatively, anyone who meets the eligibility criteria can also sign-up to take part in the study directly through the trial website: www.panoramictrial.org
All participants can take part from their own homes, without needing to visit a clinic or hospital. Participants will either be allocated to the new antiviral treatment arm (which they will follow in addition to standard care) or to the standard care arm, with treatments sent via courier.
You can read more about the study launch in the East of England on our CRN Eastern website
Coronavirus Vaccine Research
Vaccines are the most effective way to prevent infectious diseases.
They're designed so they do not give people the infection they're protecting against.
Research into vaccines is the only way to find out which vaccines will work. Researchers need people to take part in their studies so they can find out which possible new vaccine works best.
Please click on this link to find out more.
The Peninsula Practice is taking part in the national PRINCIPLE clinical trial.
ATTACK – Aspirin To Target Arterial Events in Chronic Kidney Disease
Why is the this study important?
It is estimated that there are at least 5 million people with Chronic Kidney Disease in the UK that are at increased risk of Cardiovascular Disease – this trial should give the evidence required to prove one way or the other whether aspirin should be offered to our patients with Chronic Kidney Disease to prevent heart disease or a stroke.
GLoW – Glucose Lowering Through Weight Management
Why is this study important?
Type 2 diabetes is typically characterised as an irreversible condition. However, there is evidence that people with Type 2 diabetes can achieve good glucose control or even remission through weight loss. This trial will looks at whether a tailored behavioural weight management programme achieves better glucose control than education alone and whether any improvements in health and wellbeing justify the higher cost of the programme.